Effect of CGF on Postoperative Edema in Third Molar Surgery
Evaluation of the Effect of Concentrated Growth Factor (CGF) on Postoperative Edema in Bilateral Impacted Third Molar Surgery: A Randomized Controlled Clinical Study
1 other identifier
interventional
49
1 country
1
Brief Summary
The purpose of this study is to evaluate the effects of concentrated growth factor (CGF) on edema after bilateral impacted third molar surgery and to determine its contribution to the healing process. The main question it aims to answer is: Is CGF effective on reducing the edema in impacted third molar surgery? Researchers compare the edema amount on the CGF-applied and CGF free sides after impacted third molar surgery. The edema measurements are performed on the second and seventh days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2018
CompletedFirst Submitted
Initial submission to the registry
March 12, 2025
CompletedFirst Posted
Study publicly available on registry
March 25, 2025
CompletedMarch 25, 2025
March 1, 2025
8 months
March 12, 2025
March 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative edema amounts on CGF-applied and CGF free sides in bilateral impacted third molar surgery
Edema measurements are made at three points on the patients before the operation, on the 2nd and 7th days after the operation. These measurements are made between the external canthus-angulus mandible, tragus-commissura and tragus-pogonium. In order to ensure standardization, all measurements are made by the same physician with the patient's head position in the same direction.
Before operation to the end of the operation at seven days
Study Arms (2)
CGF
EXPERIMENTALParticipants received CGF after the operation on one side
non-CGF
NO INTERVENTIONThe other extraction socket is left empty
Interventions
Bilaterally impacted third molar of the patients areremoved surgically and concentrated growth factor isplaced in one of the extraction sockets.
Eligibility Criteria
You may qualify if:
- Patients with bilateral, symmetrical, bone-retained (vertical, mesioangular, horizontal) impacted wisdom teeth in the mandible, regardless of gender
- Patients without any systemic disease
- Patients who have been informed about the duration, purpose and requirements of the study and who have signed the informed consent form voluntarily.-
You may not qualify if:
- Having a disease affecting general health that requires the application of prophylactic antimicrobial agents
- Having a systemic viral, fungal or bacterial infection
- Patients with acute or chronic maxillary sinusitis
- Suspected or diagnosed pregnancy and nursing mothers
- Patients with heart and vascular diseases
- Patients with liver disease, haematological disease and neoplastic disease
- Patients who have recently received anti-inflammatory therapy
- Patients with chronic medication use (antihistamines, NSAIDs, steroids and antidepressants)
- Patients predisposed to psychotic or psychopathic tendencies
- Patients with rheumatic diseases, blood diseases, diabetes mellitus
- Patients at cardiological risk of infective endocarditis
- Patients under antibiotic pressure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ege Universitylead
Study Sites (1)
Ege University Faculty of Dentistry
Izmir, Bornova, 35040, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mert Zeytinoglu
Ege University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof. Dr.
Study Record Dates
First Submitted
March 12, 2025
First Posted
March 25, 2025
Study Start
May 1, 2017
Primary Completion
January 1, 2018
Study Completion
June 5, 2018
Last Updated
March 25, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share